LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.4850
-0.0100 (-2.02%)
At close: Aug 21, 2026
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 88.16 million as of August 21, 2026. Its market cap has increased by 37.22% in one year.
Market Cap
88.16M
Enterprise Value
62.38M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
ChartMarket Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 88.16M, an increase of 66.41%. That is a compound annual growth rate of 20.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 88.16M | -32.59% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 136.12M |
| Recce Pharmaceuticals | 112.30M |
| Alterity Therapeutics | 108.75M |
| Paradigm Biopharmaceuticals | 103.95M |
| Prescient Therapeutics | 80.97M |
| Immutep | 79.58M |
| Arovella Therapeutics | 77.36M |
| Amplia Therapeutics | 77.00M |